NO20042114L - Nye dipeptidylpeptidase IV (DP-IV)-inhibitorer som anti-diabetesmidler - Google Patents
Nye dipeptidylpeptidase IV (DP-IV)-inhibitorer som anti-diabetesmidlerInfo
- Publication number
- NO20042114L NO20042114L NO20042114A NO20042114A NO20042114L NO 20042114 L NO20042114 L NO 20042114L NO 20042114 A NO20042114 A NO 20042114A NO 20042114 A NO20042114 A NO 20042114A NO 20042114 L NO20042114 L NO 20042114L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- dipeptidyl peptidase
- diabetic agents
- novel dipeptidyl
- novel
- Prior art date
Links
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 title 2
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 title 2
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0125446.5A GB0125446D0 (en) | 2001-10-23 | 2001-10-23 | Novel anti-diabetic agents |
| PCT/GB2002/004787 WO2003035067A1 (fr) | 2001-10-23 | 2002-10-23 | Inhibiteurs de dipeptidyl peptidase iv (dp-iv) tenant lieu d'agents anti-diabetiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042114L true NO20042114L (no) | 2004-07-21 |
Family
ID=9924376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042114A NO20042114L (no) | 2001-10-23 | 2004-05-19 | Nye dipeptidylpeptidase IV (DP-IV)-inhibitorer som anti-diabetesmidler |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7144886B2 (fr) |
| EP (1) | EP1450794A1 (fr) |
| JP (1) | JP2005510499A (fr) |
| KR (1) | KR20040049321A (fr) |
| CN (1) | CN1329375C (fr) |
| AR (1) | AR037247A1 (fr) |
| CA (1) | CA2464256A1 (fr) |
| GB (1) | GB0125446D0 (fr) |
| HU (1) | HUP0402403A3 (fr) |
| IL (1) | IL161192A0 (fr) |
| MX (1) | MXPA04003828A (fr) |
| NO (1) | NO20042114L (fr) |
| NZ (1) | NZ532044A (fr) |
| PL (1) | PL370149A1 (fr) |
| RU (1) | RU2004110055A (fr) |
| UY (1) | UY27511A1 (fr) |
| WO (1) | WO2003035067A1 (fr) |
| ZA (1) | ZA200402500B (fr) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| WO2003002553A2 (fr) | 2001-06-27 | 2003-01-09 | Smithkline Beecham Corporation | Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase |
| DE60223920T2 (de) | 2001-06-27 | 2008-11-13 | Smithkline Beecham Corp. | Pyrrolidine als dipeptidyl-peptidase-inhibitoren |
| AU2002322344C1 (en) | 2001-06-27 | 2006-02-16 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| WO2004099134A2 (fr) * | 2003-05-05 | 2004-11-18 | Prosidion Ltd. | Inhibiteurs de la dp iv a base de glutaminyle |
| DE602004026289D1 (de) | 2003-05-05 | 2010-05-12 | Probiodrug Ag | Glutaminylcyclase-hemmer |
| EP1625122A1 (fr) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Inhibiteurs de dipeptidyl peptidase |
| US20050070531A1 (en) | 2003-08-13 | 2005-03-31 | Syrrx, Inc. | Dipeptidyl peptidase inhibitors |
| EP1675578B9 (fr) | 2003-10-15 | 2014-06-25 | Probiodrug AG | Inhibiteurs de glutaminyl et glutamate cyclases pour le traitement des malaides neurodegeneratives fbd et fdd |
| DE10348044A1 (de) | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| DE10348023A1 (de) * | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| CA2545641A1 (fr) | 2003-11-17 | 2005-06-02 | Novartis Ag | Utilisation de composes organiques |
| BRPI0507007A (pt) | 2004-01-20 | 2007-06-05 | Novartis Ag | formulação e processo de compressão direta |
| CN1918131B (zh) | 2004-02-05 | 2011-05-04 | 前体生物药物股份公司 | 谷氨酰胺酰基环化酶抑制剂 |
| DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| MX2007011453A (es) * | 2005-04-22 | 2008-02-12 | Alantos Pharmaceuticals Holding Inc | Inhibidores de la dipeptidil peptidasa-iv. |
| MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| KR20100114944A (ko) * | 2005-08-11 | 2010-10-26 | 에프. 호프만-라 로슈 아게 | Ｄｐｐ-ｉｖ 억제제를 포함하는 약학 조성물 |
| US20070060530A1 (en) | 2005-09-14 | 2007-03-15 | Christopher Ronald J | Administration of dipeptidyl peptidase inhibitors |
| EP1924567B1 (fr) | 2005-09-16 | 2012-08-22 | Takeda Pharmaceutical Company Limited | Inhibiteurs de dipeptidylpeptidase |
| GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| CN103536924A (zh) | 2006-04-11 | 2014-01-29 | 艾尼纳制药公司 | 使用gpr119受体鉴定可用于增加个体骨质量的化合物的方法 |
| EP2007734A1 (fr) | 2006-04-12 | 2008-12-31 | Probiodrug AG | Inhibiteurs d'enzyme |
| JP5379692B2 (ja) | 2006-11-09 | 2013-12-25 | プロビオドルグ エージー | 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体 |
| TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| EP2091948B1 (fr) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Nouveaux inhibiteurs de glutaminylcyclase |
| WO2008128985A1 (fr) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase |
| EP2108960A1 (fr) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Procédés d'utilisation d'un récepteur couplé à protéine G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement des conditions modulées de secrétagogues BY (PYY) et composés utiles dans le traitement des conditions par PYY |
| AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
| WO2011029920A1 (fr) | 2009-09-11 | 2011-03-17 | Probiodrug Ag | Dérivés hétérocycliques en tant qu'inhibiteurs de glutaminyle cyclase |
| EP2542549B1 (fr) | 2010-03-03 | 2016-05-11 | Probiodrug AG | Inhibiteurs de glutaminyl cyclase |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| AU2011237775A1 (en) | 2010-04-06 | 2012-11-22 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| EA201390421A1 (ru) | 2010-09-22 | 2013-09-30 | Арена Фармасьютикалз, Инк. | Модуляторы рецептора gpr119 и лечение связанных с ним нарушений |
| US8530670B2 (en) | 2011-03-16 | 2013-09-10 | Probiodrug Ag | Inhibitors |
| US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012145361A1 (fr) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci |
| WO2012145604A1 (fr) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci |
| US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012170702A1 (fr) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci |
| WO2013055910A1 (fr) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés |
| TWI500613B (zh) | 2012-10-17 | 2015-09-21 | Cadila Healthcare Ltd | 新穎之雜環化合物 |
| WO2014074668A1 (fr) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulateurs de gpr119 et traitement de troubles associés à ceux-ci |
| GB201415598D0 (en) | 2014-09-03 | 2014-10-15 | Univ Birmingham | Elavated Itercranial Pressure Treatment |
| KR20220070057A (ko) | 2015-03-09 | 2022-05-27 | 인테크린 테라퓨틱스, 아이엔씨. | 비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법 |
| WO2018162722A1 (fr) | 2017-03-09 | 2018-09-13 | Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke | Inhibiteurs de dpp-4 à utiliser dans le traitement de fractures osseuses |
| EP3606527A1 (fr) | 2017-04-03 | 2020-02-12 | Coherus Biosciences, Inc. | Agoniste de ppar-gamma pour le traitement de la paralysie supranucléaire progressive |
| DK3461819T3 (da) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | Inhibitorer af glutaminylcyklase |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959248A (en) * | 1974-04-03 | 1976-05-25 | Merck & Co., Inc. | Analogs of thyrotropin-releasing hormone |
| IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| DE19823831A1 (de) * | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
| GB9928330D0 (en) * | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
| GB0010183D0 (en) | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
| GB0010188D0 (en) * | 2000-04-26 | 2000-06-14 | Ferring Bv | Inhibitors of dipeptidyl peptidase IV |
-
2001
- 2001-10-23 GB GBGB0125446.5A patent/GB0125446D0/en not_active Ceased
-
2002
- 2002-10-22 AR ARP020103995A patent/AR037247A1/es unknown
- 2002-10-22 UY UY27511A patent/UY27511A1/es not_active Application Discontinuation
- 2002-10-23 NZ NZ532044A patent/NZ532044A/en unknown
- 2002-10-23 KR KR10-2004-7005917A patent/KR20040049321A/ko not_active Ceased
- 2002-10-23 IL IL16119202A patent/IL161192A0/xx unknown
- 2002-10-23 JP JP2003537634A patent/JP2005510499A/ja not_active Withdrawn
- 2002-10-23 PL PL02370149A patent/PL370149A1/xx not_active Application Discontinuation
- 2002-10-23 CN CNB028208544A patent/CN1329375C/zh not_active Expired - Fee Related
- 2002-10-23 RU RU2004110055/04A patent/RU2004110055A/ru not_active Application Discontinuation
- 2002-10-23 EP EP02801961A patent/EP1450794A1/fr not_active Withdrawn
- 2002-10-23 MX MXPA04003828A patent/MXPA04003828A/es active IP Right Grant
- 2002-10-23 CA CA002464256A patent/CA2464256A1/fr not_active Abandoned
- 2002-10-23 HU HU0402403A patent/HUP0402403A3/hu unknown
- 2002-10-23 US US10/491,288 patent/US7144886B2/en not_active Expired - Fee Related
- 2002-10-23 WO PCT/GB2002/004787 patent/WO2003035067A1/fr not_active Ceased
-
2004
- 2004-03-30 ZA ZA200402500A patent/ZA200402500B/xx unknown
- 2004-05-19 NO NO20042114A patent/NO20042114L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB0125446D0 (en) | 2001-12-12 |
| WO2003035067A1 (fr) | 2003-05-01 |
| UY27511A1 (es) | 2003-04-30 |
| NZ532044A (en) | 2005-03-24 |
| IL161192A0 (en) | 2004-08-31 |
| CN1575171A (zh) | 2005-02-02 |
| HUP0402403A3 (en) | 2009-05-28 |
| CN1329375C (zh) | 2007-08-01 |
| US20050004205A1 (en) | 2005-01-06 |
| EP1450794A1 (fr) | 2004-09-01 |
| US7144886B2 (en) | 2006-12-05 |
| HUP0402403A2 (hu) | 2005-04-28 |
| PL370149A1 (en) | 2005-05-16 |
| KR20040049321A (ko) | 2004-06-11 |
| MXPA04003828A (es) | 2004-07-16 |
| RU2004110055A (ru) | 2005-10-20 |
| ZA200402500B (en) | 2005-01-24 |
| AR037247A1 (es) | 2004-11-03 |
| JP2005510499A (ja) | 2005-04-21 |
| CA2464256A1 (fr) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20042114L (no) | Nye dipeptidylpeptidase IV (DP-IV)-inhibitorer som anti-diabetesmidler | |
| NO20041709L (no) | N-substituerte pyrrolidinderivater som dipeptidyl peptidase IV inhibitorer | |
| EE200200604A (et) | Dipeptidüüli peptidaasi IV inhibiitorid | |
| DE602004010206D1 (de) | Dipeptidyl Peptidase Inhibitoren. | |
| EP1465891A4 (fr) | Inhibiteurs de la dipeptidyl peptidase iv | |
| NO20082048L (no) | Ny formulering | |
| PL370220A1 (en) | Inhibitors of dipeptidyl peptidase iv | |
| DK1427910T3 (da) | Cheleringssammensætninger til fraktureringsvæske | |
| NO20031574D0 (no) | Nye dipeptidylpeptidase IV-inhibitorer og deres anvendelse for reduksjon avblodtrykksnivåer | |
| TW200634018A (en) | Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and uses | |
| HUS1400007I1 (hu) | Dipeptidil-peptidáz inhibitorok | |
| AU2003286776A1 (en) | Novel inhibitors of dipeptidyl peptidase iv | |
| NO20035603D0 (no) | Fluorpyrrolidiner som dipeptidyl peptidase inhibitorer | |
| ZA200306041B (en) | Pyridine matrix metalloproteinase inhibitors. | |
| AU2002228302A1 (en) | Matrix metalloproteinase inhibitors | |
| NO20035775L (no) | 3-fluor-pyrrolidiner som anti-diabetesmidler | |
| EP1499336A4 (fr) | Inhibiteurs de protease | |
| ATE429431T1 (de) | 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren | |
| IL165043A0 (en) | broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors | |
| PL375304A1 (en) | N-sulfonylpiperidines as metalloproteinase inhibitors (tace) | |
| HRP20040936A2 (en) | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors | |
| HK1068552A (en) | Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents | |
| ATE390419T1 (de) | 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-o - derivate als pde4-inhibitoren | |
| NO20032290L (no) | Nye forbindelser for anvendelse som HIV-protease-inhibitorer | |
| HK1065532A (en) | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |